We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

17 hedge funds and large institutions have $820K invested in Capricor Therapeutics in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $677K → $820K (+$143K)

0.04% more ownership

Funds ownership: 0.53% → 0.57% (+0.04%)

6% less funds holding

Funds holding: 18 → 17 (-1)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
US Bancorp
US Bancorp
Minnesota
+$38.4K
2
Citadel Advisors
Citadel Advisors
Florida
+$22.6K
3
UBS Group
UBS Group
Switzerland
+$10.2K
4
CBA
Coastal Bridge Advisors
Connecticut
+$1.02K

Top Sellers

1
VF
Virtu Financial
New York
-$8K
2
Bank of America
Bank of America
North Carolina
-$1.52K
3
BlackRock
BlackRock
New York
-$1.08K
4
AG
Advisor Group
Arizona
-$1K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$412
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
1
Brown Advisory
Maryland
$398K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$142K – – –
CBA
3
Coastal Bridge Advisors
Connecticut
$56K +$1.02K +199 +2%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$55K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$36K +$22.6K +4,396 +133%
US Bancorp
6
US Bancorp
Minnesota
$35K +$38.4K +7,463 New
AA
7
Apriem Advisors
California
$23K – – –
Northern Trust
8
Northern Trust
Illinois
$21K -$154 -30 -0.6%
BlackRock
9
BlackRock
New York
$20K -$1.08K -210 -5%
UBS Group
10
UBS Group
Switzerland
$16K +$10.2K +1,976 +142%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$11K -$412 -80 -3%
HIIFS
12
Harel Insurance Investments & Financial Services
Israel
$3K – – –
Bank of America
13
Bank of America
North Carolina
$1K -$1.52K -296 -54%
CFN
14
Cordasco Financial Network
Florida
$1K – – –
FANJ
15
Financial Architects (New Jersey)
New Jersey
$1K – – –
LTFS
16
Ladenburg Thalmann Financial Services
Florida
$1K – – –
VF
17
Virtu Financial
New York
– -$8K -2,025 Closed
AG
18
Advisor Group
Arizona
– -$1K -300 Closed

CAPR Hedge Fund Activity: Q1 2019 in Review

17 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q1 2019, worth a combined $820K — up 21% from $677K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CAPR and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.

The largest buyer was US Bancorp, opening a new position worth an estimated $38.4K. The largest seller was Virtu Financial, exiting entirely with an estimated $8K sold.

  • 17 institutional investors held Capricor Therapeutics (CAPR) as of Q1 2019, down from 18 in Q4 2018.
  • Funds reported $820K of Capricor Therapeutics stock for Q1 2019, up 21% quarter-over-quarter.
  • 1 fund opened new Capricor Therapeutics positions in Q1 2019 and 2 closed out, a net change of -1 holder.
  • The largest Capricor Therapeutics buyer in Q1 2019 was US Bancorp, an estimated $38.4K added.
  • The largest Capricor Therapeutics seller in Q1 2019 was Virtu Financial, an estimated $8K sold.

Based on aggregated 13F filings for Q1 2019.